Nancy Hague
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
- Oncology 8
- Chemokine receptors and signaling 5
- Cytokine Signaling Pathways and Interactions 3
-
- Ion channel regulation and function 3
- Glycosylation and Glycoproteins Research 2
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Stephanie Cooper (5 shared papers)G Cacalano (2 shared papers)H E Broxmeyer (4 shared papers)Karen Carver-Moore (1 shared paper)Susanne Baumhueter (1 shared paper)HE Broxmeyer (1 shared paper)Harold Thibodeaux (1 shared paper)Jill Cheng (1 shared paper)
- Journals
- Blood (3 papers)British Journal of Pharmacology (2 papers)Annals of Hematology (2 papers)Transfusion (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Nancy Hague
15 papers receiving 507 citations
Peers
Comparison fields: 5 of 67
- Hematology 153
- Immunology and Allergy 71
- Immunology 233
- Toxicology 35
- Oncology 204
Countries citing papers authored by Nancy Hague
This map shows the geographic impact of Nancy Hague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Hague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Hague more than expected).
Fields of papers citing papers by Nancy Hague
This network shows the impact of papers produced by Nancy Hague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Hague. The network helps show where Nancy Hague may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Hague, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 174 | |
| 2 | 1996 | 98 | |
| 3 | 1995 | 58 | |
| 4 | 1998 | 36 | |
| 5 | 1990 | 30 | |
| 6 | 1993 | 23 | |
| 7 | 1997 | 19 | |
| 8 | 1995 | 18 | |
| 9 | 1995 | 18 | |
| 10 | 2021 | 11 | |
| 11 | 1995 | 9 | |
| 12 | 1992 | 9 | |
| 13 | Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. | 1995 | 9 |
| 14 | 1994 | 5 | |
| 15 | 1997 | 3 |
About Nancy Hague
Nancy Hague is a scholar working on Oncology, Molecular Biology, Immunology, Cardiology and Cardiovascular Medicine and Hematology, having authored 15 papers that have together received 520 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (5 papers), Cytokine Signaling Pathways and Interactions (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Ion channel regulation and function (3 papers), Immune cells in cancer (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Glycosylation and Glycoproteins Research (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Hematology (153 citations), Immunology and Allergy (71 citations), Immunology (233 citations), Toxicology (35 citations) and Oncology (204 citations). Nancy Hague has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Stephanie Cooper, G Cacalano, H E Broxmeyer, Karen Carver-Moore, Susanne Baumhueter, HE Broxmeyer, Harold Thibodeaux, Jill Cheng, Mark W. Moore and Rebecca C. Thomas. Their work appears in journals such as Blood, British Journal of Pharmacology, Annals of Hematology, Transfusion and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.